TIFFANY LEHMAN: Open Payments
NPI 1922792779 · JEFFERSON CITY, MO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$642 in 35 payments from 12 companies in 2025. Trend: 2023 $304 · 2024 $683 · 2025 $642
Food & beverage: $642
| Company | Payments | Amount |
|---|---|---|
| BIOTRONIK INC. | 6 | $110 |
| Amgen Inc. | 6 | $94 |
| Novo Nordisk Inc | 3 | $77 |
| Novartis Pharmaceuticals Corporation | 4 | $71 |
| AstraZeneca Pharmaceuticals LP | 4 | $67 |
| E.R. Squibb & Sons, L.L.C. | 3 | $55 |
| ABIOMED | 2 | $42 |
| PFIZER INC. | 2 | $35 |
| Alnylam Pharmaceuticals Inc. | 2 | $33 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $22 |
Products named: BIOMONITOR, REPATHA, Wegovy, ELIQUIS, LEQVIO, WAINUA, AMVUTTRA, JARDIANCE.
Industry payments across MO — which companies pay providers there.
